We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Peripheral Blood Flow Cytometry Classifies Pediatric Acute Leukemia

By LabMedica International staff writers
Posted on 25 Feb 2019
Historically, flow cytometry performed on the bone marrow aspirate (BMFC) has been the standard for the immunophenotypic characterization of acute leukemia. More...
Recent data have demonstrated the high sensitivity and specificity of peripheral blood flow cytometry for the diagnosis of pediatric leukemia.

Peripheral blood flow cytometry (PBFC) represents a less invasive approach to the immunophenotyping of the leukemic clone, which can also facilitate a quicker diagnosis and the opportunity to subsequently perform concurrent central venous access device placement, lumbar puncture with intrathecal chemotherapy administration, and bone marrow biopsy, if necessary, under a single anesthetic.

Medical laboratory scientists at St. Jude Children's Research Hospital (Memphis, TN, USA) collected peripheral blood and BM samples were collected in preservative‐free heparin or EDTA. Cells were washed twice in phosphate‐buffered saline and labeled with various combinations of monoclonal antibodies conjugated to fluorochromes directed against surface antigens or isotype‐matched nonreactive monoclonal antibodies. The samples were processed and analyzed using four or eight color stained cell preparations with FACSCalibur or FACSCanto II flow cytometers with FACSDiva software. A minimum of 20,000 cells per tube were counted. A diagnostic minimal residual disease (MRD) panel was also implemented.

The team identified 290 PBFC samples with concurrent BM evaluation. Based on the final immunophenotypic classification, the cases were distributed as follows: 108 B‐lymphoblastic leukemia (B‐ALL), 57 T‐lymphoblastic leukemia (T‐ALL), 116 acute myeloid leukemia (AML), and nine mixed‐phenotype acute leukemia (MPAL). Among all cases, five had a diagnostically significant discrepancy between PBFC and BM evaluation. In three cases, the immunophenotype by PBFC was consistent with early T‐cell precursor ALL (ETP‐ALL), whereas BM evaluation demonstrated MPAL. Two cases were suspicious for acute megakaryoblastic leukemia (AMKL) and MPAL, T/myeloid by PBFC, but were diagnosed as B‐ALL and T‐ALL in the BM.

The authors concluded that immunophenotypic classification by PBFC is accurate in more than 98% of all cases of pediatric leukemia with the rare exceptions of suspected ETP‐ALL, MPAL, and AMKL. These PBFC diagnoses should be confirmed with BM immunophenotyping. The study was published in the January 2019 issue of the journal Pediatric Blood & Cancer.

Related Links:
St. Jude Children's Research Hospital


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.